COPPER 100

GHK-CU (100 mg Vial) Dosage Protocol

GHK-Cu (100 mg Vial) Dosage Protocol

Table of Contents

GHK-Cu dosage protocols utilize this naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) to support skin rejuvenation, wound healing, and tissue repair[1][2]. GHK-Cu stimulates collagen and elastin production, promotes angiogenesis, and delivers powerful antioxidant and anti-inflammatory benefits[3][4]. Human studies demonstrate improved skin thickness, reduced wrinkles, and enhanced dermal density with GHK-Cu application[2]. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

  • Reconstitute: Add 3.0 mL bacteriostatic water → ~33.3 mg/mL concentration.
  • Typical daily range: 1–2 mg once daily (gradual titration over 12 weeks).
  • Easy measuring: At 33.3 mg/mL, 1 unit = 0.01 mL ≈ 333 mcg on a U-100 insulin syringe.
  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); use within 30 days.
Educational guide for reconstitution and weekly dosing

Standard / Gradual Approach (3 mL = ~33.3 mg/mL)

WeekDaily Dose (mg)Units (per injection) (mL)
Weeks 1–41.0 mg3 units (0.03 mL)
Weeks 5–81.5 mg4.5 units (0.045 mL)
Weeks 9–122.0 mg6 units (0.06 mL)

Frequency: Inject once daily subcutaneously, 5 days per week (Mon–Fri) with weekends off[5]For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall; avoid foaming.
  3. Gently swirl/roll until dissolved (do not shake).
  4. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light; use within 30 days[6][7].
Important: This guide is for educational purposes only and is not medical advice. Retatrutide is not FDA-approved and is available only for research use. All dosing must follow trial protocols.

Plan based on an 8–12 week daily protocol (5 days/week) with gradual titration.

  • Peptide Vials (GHK-Cu, 100 mg each):

     

    • 8 weeks (~40 injections, ~50 mg total) ≈ 1 vial
    • 12 weeks (~60 injections, ~90 mg total) ≈ 1 vial
  • Insulin Syringes (U-100, 30- or 50-unit preferred):

     

    • Per week: 5 syringes (1/day, 5 days)
    • 8 weeks: 40 syringes
    • 12 weeks: 60 syringes
  • Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.

     

    • 8–12 weeks (1 vial): 3 mL → 1 × 10 mL bottle
  • Alcohol Swabs: One for the vial stopper + one for the injection site each day.

     

    • Per week: 10 swabs (2/day, 5 days)
    • 8 weeks: 80 swabs → recommend 1 × 100-count box
    • 12 weeks: 120 swabs → recommend 2 × 100-count boxes

Concise summary of the once-daily regimen.

  • Goal: Support skin rejuvenation, collagen synthesis, wound healing, and anti-aging tissue repair[2][3].
  • Schedule: Daily subcutaneous injections, 5 days on / 2 days off, for 8–12 weeks.
  • Dose Range: 1–2 mg daily with gradual titration.
  • Reconstitution: 3.0 mL per 100 mg vial (~33.3 mg/mL) for accurate unit measurements.
  • Storage: Lyophilized frozen at −20 °C; reconstituted refrigerated; use within 30 days.
Suggested weekly titration approach from clinical trials.
  • Start: 1.0 mg daily for Weeks 1–4; increase to 1.5 mg for Weeks 5–8.
  • Target: 2.0 mg daily by Weeks 9–12.
  • Frequency: Once per day (subcutaneous), 5 days per week.
  • Cycle Length: 8–12 weeks; take 2–4 weeks off before repeating[5].
  • Timing: Any consistent time; rotate injection sites.
Proper storage preserves peptide quality and stability.
  • Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable for 12+ months[6].
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 30 days; avoid freeze–thaw[7].
  • Allow vials to reach room temperature before opening to reduce condensation uptake.
Practical considerations for consistency and safety.
  • Use new sterile insulin syringes (30- or 50-unit recommended for small volumes); dispose in a sharps container.
  • Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation[8].
  • Inject slowly; wait a few seconds before withdrawing the needle.
  • Document daily dose and site rotation to maintain consistency.
  • Reconstituted solution should appear clear with a blue tint (from copper); discard if cloudy or discolored.

GHK-Cu functions as a “signal peptide” that triggers tissue repair processes by chelating copper(II) ions and delivering this essential trace metal to cells in a bioavailable form[1][9]. Copper is a critical cofactor for enzymes involved in collagen synthesis (lysyl oxidase) and antioxidant defense (superoxide dismutase). Genomic studies show GHK-Cu modulates over 30% of human genes toward a regenerative, anti-aging phenotype[2][10]. The peptide stimulates production of VEGF and bFGF in fibroblasts, promoting angiogenesis and blood flow to injured tissue[3]. GHK-Cu also recruits immune cells to injury sites, increases collagen/elastin/glycosaminoglycan synthesis, and regulates matrix metalloproteinases for balanced tissue remodeling[2][4].

Observations from preclinical and clinical literature.

  • Skin Rejuvenation: Clinical studies show increased skin thickness, improved dermal collagen density, and reduced wrinkle depth with GHK-Cu application[2].
  • Wound Healing: Promotes angiogenesis, granulation tissue formation, and accelerated wound closure in preclinical models[3][4].
  • Anti-Inflammatory: Suppresses pro-inflammatory cytokines (TNF-α, IL-6) and provides antioxidant protection[1][11].
  • Hair Growth: Observed to enlarge hair follicle size and increase growth rate in studies[2].
  • Safety Profile: Excellent tolerability with no serious adverse effects noted; extremely wide safety margin in toxicology studies[9][10].
  • Occasional mild injection-site reactions (transient redness or stinging) may occur with subcutaneous administration.
Complementary strategies for optimal metabolic outcomes.
  • Ensure adequate protein and vitamin C intake to support collagen synthesis.
  • Maintain proper hydration—tissue repair processes require sufficient water.
  • Consider complementary skincare routines (sunscreen, moisturizers) to protect treated skin.
  • Prioritize sleep and stress management to support recovery and tissue regeneration

General subcutaneous guidance from clinical best-practice resources[8].

  • Clean the vial stopper and skin with alcohol; allow to dry.
  • Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[8].
  • Do not aspirate for subcutaneous injections; inject slowly and steadily.
  • Wait 5–10 seconds before withdrawing; dispose of syringe in sharps container.
  • Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.

This content is for educational purposes only and is not medical advice.

 

 

References

— Comprehensive review of GHK-Cu mechanisms: copper delivery, anti-inflammatory effects, tissue repair
— Gene expression, skin remodeling, collagen synthesis, clinical cosmetic study results
— GHK-Cu stimulates fibroblasts, collagen, angiogenesis; wound healing review
— Review of GHK/GHK-Cu in anti-aging skincare; collagen, elastin, GAG production
— Practical dosing protocols, frequency recommendations, cycle guidelines
— Peptide storage guidelines: −20°C long-term, room temp stability, moisture prevention
— Best practices for peptide reconstitution, storage at 4°C, avoiding freeze-thaw cycles
— NIH guidance on subcutaneous injection technique, site selection, 45° angle
— Safety margin, copper delivery mechanisms, systemic wound healing doses
— Gene modulation analysis; antioxidant, anti-anxiety, regenerative activities; safety data
— Preclinical neuroprotective effects; anti-inflammatory action in aging mice

— GHK-Cu (100 mg) product page (quality and batch documentation)

Mechanism Breakdown — 3rd Party Analysis

This video provides an external overview on GHK-CU

External Source

Titration schedule.

Standard research titration model. Adjust under qualified clinical observation only. Not for human therapeutic use.

Phase 01

Wk 1 — 4

3 units

Initiation · tolerance assessment

Phase 02

Wk 5 — 8

4 units

Once daily

Standard titration step

Phase 03

Wk 9 — 12

4.5 units

Once daily

Maintenance evaluation

Phase 04

Wk 13+

6 units

Once daily

Optional research extension

Research use only.

Copper 100 is supplied strictly for in-vitro laboratory research and biochemical analysis. It is not intended for human consumption, diagnostic use, veterinary application or therapeutic administration of any kind.

Handling must be performed by qualified personnel in compliance with applicable institutional and jurisdictional safety standards. The information contained on this protocol sheet is provided for educational and reference purposes only and does not constitute medical advice.
  • Not for human use
  • Store at 2–8 °C, protected from light
  • Reconstitute under aseptic conditions
  • Document all research observations
 

Blue Tier Catalogue

Explore the full British Dragon research line.

Premium-tier compounds engineered for serious metabolic, longevity and performance research programs.